経口避妊薬の世界市場レポート 2025年

経口避妊薬の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR15.3％で542億1,000万米ドルに成長します。予測期間の成長は、人口の増加、女性の地位向上、ヘルスケア支出の増加、ヘルスケアインフラの進歩、製品ポートフォリオの拡大に起因しています。予測期間中の主な動向としては、副作用やホルモン分泌の乱れを最小限に抑えることへの注力、非ホルモン性避妊薬や天然避妊薬の出現、継続的でオーダーメイドの避妊レジメンへのシフト、意識向上と教育イニシアティブの増加、女性のエンパワーメントの高まりと避妊選択への関与などが挙げられます。

予期される意図しない妊娠の増加は、今後数年間の経口避妊薬市場成長の原動力になると予想されます。カリフォルニア大学サンフランシスコ校（UCSF）が実施した研究によると、計画的でない妊娠や望まない妊娠を特徴とする「意図せざる妊娠」は、女性に経口避妊薬を1年間処方した場合、望まない妊娠や中絶の割合が大幅に減少することが示されています。世界保健機関（WHO）によると、世界の中低所得国では毎年約7400万人の女性が計画外の妊娠を経験しています。WHOの調査では、4,794人の女性が避妊具の使用を中止した後、意図しない妊娠をしていることが明らかになっています。このように、意図しない妊娠を防ぐことが、経口避妊薬市場の成長を促す重要な要因となっています。

ヘルスケア支出の増加は、今後の経口避妊薬市場の成長を促進すると予想されます。ヘルスケア支出とは、定義された時間枠内でヘルスケアサービスや製品に割り当てられる財政投資を含む総資源を指します。ヘルスケア支出の増加は、ヘルスケアへの全体的なアクセスを向上させ、家族計画サービス、診察、手頃な価格の処方へのアクセス強化を通じて経口避妊薬の普及を促進し、市場の成長を支えます。例えば、2023年5月、英国の国家統計機関であるOffice for National Statisticsは、2022年の英国のヘルスケア支出が約3,548億8,000万米ドル（2,830億英ポンド）に達し、2021年と比較して名目上0.7％増加したと報告しました。このように、ヘルスケア支出の増加が経口避妊薬市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界経口避妊薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の経口避妊薬市場：成長率分析
• 世界の経口避妊薬市場の実績：規模と成長, 2019-2024
• 世界の経口避妊薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界経口避妊薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の経口避妊薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み合わせ
• プロゲスチンのみ
• その他のタイプ
• 世界の経口避妊薬市場：カテゴリ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジェネリック
• ブランド
• 世界の経口避妊薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• クリニック
• オンラインチャンネル
• 公共チャンネルとNGO
• その他の流通チャネル
• 世界の経口避妊薬市場、組み合わせのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一相性配合錠剤
• 多相性配合錠剤
• 延長サイクル複合ピル
• 世界の経口避妊薬市場、プロゲスチンのみのタイプ別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 毎日服用するプロゲスチンのみのピル
• プロゲスチンのみの緊急避妊薬
• 世界の経口避妊薬市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低用量経口避妊薬
• 高用量経口避妊薬
• 非ホルモン経口避妊薬（開発中または代替製剤）

第7章 地域別・国別分析

• 世界の経口避妊薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の経口避妊薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経口避妊薬市場：競合情勢
• 経口避妊薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Zydus Lifesciences Ltd.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Aurobindo Pharma Limited
• Cipla Inc.
• Dr. Reddy's Laboratories Ltd.
• Amneal Pharmaceuticals LLC
• Lupin Pharmaceuticals Inc.
• Glenmark Pharmaceuticals
• Mankind Pharma Ltd.
• Mayne Pharma
• HLL Lifecare Limited
• Famy Care Ltd.
• Mylan N.V.
• Novartis AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 経口避妊薬市場2029：新たな機会を提供する国
• 経口避妊薬市場2029：新たな機会を提供するセグメント
• 経口避妊薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oral contraceptive pills are tablets designed for contraception, containing hormones that inhibit the release of eggs from the ovaries. Typically, these pills contain both progestin and estrogen. Commonly known as birth control pills, they consist of hormones that prevent the ovaries from releasing eggs. The majority of oral contraceptives incorporate both estrogen and progestin.

The market for oral contraceptive pills is categorized by type into combination, progestin-only, and others, by category into generic and branded, and by distribution channel into hospital pharmacy, retail pharmacy, clinics, online channels, public channels and NGOs, among others.

The oral contraceptive pills market research report is one of a series of new reports from The Business Research Company that provides oral contraceptive pills market statistics, including oral contraceptive pills industry global market size, regional shares, competitors with an oral contraceptive pills market share, detailed oral contraceptive pills market segments, market trends and opportunities, and any further data you may need to thrive in the oral contraceptive pills industry. This oral contraceptive pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral contraceptive pills market size has grown rapidly in recent years. It will grow from $26.82 billion in 2024 to $30.7 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing awareness, rising women's health concerns, government initiatives, changing lifestyles, market expansion.

The oral contraceptive pills market size is expected to see rapid growth in the next few years. It will grow to $54.21 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to growing population, women's empowerment, rising healthcare expenditure, advancements in healthcare infrastructure, expanding product portfolio. Major trends in the forecast period include focus on minimizing side effects and hormonal disruption, emergence of non-hormonal and natural contraceptive alternatives, shift towards continuous and tailored contraceptive regimens, increasing awareness and education initiatives, rise in female empowerment and involvement in contraceptive choices.

The anticipated rise in unintended pregnancies is expected to be a driving force behind the growth of the oral contraceptive pills market in the upcoming years. Unintended pregnancies, characterized by pregnancies that are not planned or desired, have shown a substantial decrease in rates of unwanted pregnancy and abortion when women are provided with a one-year prescription of oral contraceptives, as indicated by a study conducted by the University of California, San Francisco (UCSF). According to the World Health Organization (WHO), approximately 74 million women in low-middle-income economies globally experience unplanned pregnancies each year. The WHO's research highlights that 4,794 women had unintended pregnancies after discontinuing the use of contraceptives. Thus, the imperative to prevent unintended pregnancies is a key factor driving the growth of the oral contraceptive pills market.

The increasing healthcare expenditure is anticipated to drive the growth of the oral contraceptive pill market in the future. Healthcare expenditure refers to the total resources, including financial investments, allocated to healthcare services and products within a defined timeframe. An increase in healthcare expenditure improves overall access to healthcare, facilitating greater adoption of oral contraceptive pills through enhanced access to family planning services, consultations, and affordable prescriptions, thereby supporting market growth. For example, in May 2023, the Office for National Statistics, a UK-based national statistics organization, reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion) in 2022, marking a nominal increase of 0.7% compared to 2021. Thus, the rise in healthcare expenditures is contributing to the growth of the oral contraceptive pills market.

Key institutes and companies in the oral contraceptive pill sector are actively engaged in developing innovative solutions, exemplified by HRA Pharma, a France-based healthcare company. In July 2022, HRA Pharma introduced Opill, an over-the-counter birth control pill, and applied for approval from the Food and Drug Administration in the United States. Opill, a progestin-based contraceptive, aims to provide easy access to contraception without unnecessary obstacles.

Prominent companies in the oral contraceptive pill market are also investing in innovative products, including progestin-only oral contraceptives, to cater to a broader customer base, increase sales, and boost revenue. Progestin-only oral contraceptives contain only a synthetic form of the hormone progestin. Perrigo Company PLC, an Ireland-based manufacturer of oral contraceptive pills, secured U.S. Food and Drug Administration (FDA) approval for Opill in July 2023. Opill, the first over-the-counter birth control pill in the United States, not only offers effective pregnancy prevention but also revolutionizes contraception access by being available without a prescription. This development underscores Perrigo's commitment to transformative solutions that enhance lives and exemplifies its dedication to pioneering impactful innovations in healthcare.

In April 2023, Marksans Pharma, an India-based pharmaceutical company, completed the acquisition of Teva Pharmaceutical Industries Ltd.'s manufacturing facility for an undisclosed amount. This acquisition provides Marksans with ownership of a 47,597-square-meter facility, effectively doubling its current production capacity in India to 8 billion units per year. The expanded facility will be utilized for manufacturing various pharmaceutical products, including tablets, hard and soft gel capsules, ointments, liquids, and creams, with Teva Pharmaceutical Industries Ltd. being known for its manufacturing of oral contraceptive pills.

Major companies operating in the oral contraceptive pills market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma

North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral contraceptive pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The oral contraceptive pills market consists of sales of combined estrogen-progesterone, progesterone-only, and continuous or extended use pill. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Contraceptive Pills Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral contraceptive pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral contraceptive pills ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral contraceptive pills market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Combination; Progestin Only; Other Types
• 2) By Category: Generic; Branded
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Clinics; Online Channel; Public Channel And NGO; Other Distribution Channels
• Subsegments:
• 1) By Combination Pills: Monophasic Combination Pills; Multiphasic Combination Pills; Extended-Cycle Combination Pills
• 2) By Progestin-Only Pills: Daily Progestin-Only Pills; Progestin-Only Emergency Contraceptive Pills
• 3) By Other Types: Low-Dose Oral Contraceptive Pills; High-Dose Oral Contraceptive Pills; Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Abbvie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oral Contraceptive Pills Market Characteristics

3. Oral Contraceptive Pills Market Trends And Strategies

4. Oral Contraceptive Pills Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Oral Contraceptive Pills Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oral Contraceptive Pills PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oral Contraceptive Pills Market Growth Rate Analysis
• 5.4. Global Oral Contraceptive Pills Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oral Contraceptive Pills Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oral Contraceptive Pills Total Addressable Market (TAM)

6. Oral Contraceptive Pills Market Segmentation

• 6.1. Global Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination
• Progestin Only
• Other Types
• 6.2. Global Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Generic
• Branded
• 6.3. Global Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channel
• Public Channel And NGO
• Other Distribution Channels
• 6.4. Global Oral Contraceptive Pills Market, Sub-Segmentation Of Combination, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monophasic Combination Pills
• Multiphasic Combination Pills
• Extended-Cycle Combination Pills
• 6.5. Global Oral Contraceptive Pills Market, Sub-Segmentation Of Progestin Only, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Daily Progestin-Only Pills
• Progestin-Only Emergency Contraceptive Pills
• 6.6. Global Oral Contraceptive Pills Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Dose Oral Contraceptive Pills
• High-Dose Oral Contraceptive Pills
• Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)

7. Oral Contraceptive Pills Market Regional And Country Analysis

• 7.1. Global Oral Contraceptive Pills Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oral Contraceptive Pills Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oral Contraceptive Pills Market

• 8.1. Asia-Pacific Oral Contraceptive Pills Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oral Contraceptive Pills Market

• 9.1. China Oral Contraceptive Pills Market Overview
• 9.2. China Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oral Contraceptive Pills Market

• 10.1. India Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oral Contraceptive Pills Market

• 11.1. Japan Oral Contraceptive Pills Market Overview
• 11.2. Japan Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oral Contraceptive Pills Market

• 12.1. Australia Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oral Contraceptive Pills Market

• 13.1. Indonesia Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oral Contraceptive Pills Market

• 14.1. South Korea Oral Contraceptive Pills Market Overview
• 14.2. South Korea Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oral Contraceptive Pills Market

• 15.1. Western Europe Oral Contraceptive Pills Market Overview
• 15.2. Western Europe Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oral Contraceptive Pills Market

• 16.1. UK Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oral Contraceptive Pills Market

• 17.1. Germany Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oral Contraceptive Pills Market

• 18.1. France Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oral Contraceptive Pills Market

• 19.1. Italy Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oral Contraceptive Pills Market

• 20.1. Spain Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oral Contraceptive Pills Market

• 21.1. Eastern Europe Oral Contraceptive Pills Market Overview
• 21.2. Eastern Europe Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oral Contraceptive Pills Market

• 22.1. Russia Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oral Contraceptive Pills Market

• 23.1. North America Oral Contraceptive Pills Market Overview
• 23.2. North America Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oral Contraceptive Pills Market

• 24.1. USA Oral Contraceptive Pills Market Overview
• 24.2. USA Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oral Contraceptive Pills Market

• 25.1. Canada Oral Contraceptive Pills Market Overview
• 25.2. Canada Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oral Contraceptive Pills Market

• 26.1. South America Oral Contraceptive Pills Market Overview
• 26.2. South America Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oral Contraceptive Pills Market

• 27.1. Brazil Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oral Contraceptive Pills Market

• 28.1. Middle East Oral Contraceptive Pills Market Overview
• 28.2. Middle East Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oral Contraceptive Pills Market

• 29.1. Africa Oral Contraceptive Pills Market Overview
• 29.2. Africa Oral Contraceptive Pills Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oral Contraceptive Pills Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oral Contraceptive Pills Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oral Contraceptive Pills Market Competitive Landscape And Company Profiles

• 30.1. Oral Contraceptive Pills Market Competitive Landscape
• 30.2. Oral Contraceptive Pills Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Oral Contraceptive Pills Market Other Major And Innovative Companies

• 31.1. Zydus Lifesciences Ltd.
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Aurobindo Pharma Limited
• 31.5. Cipla Inc.
• 31.6. Dr. Reddy's Laboratories Ltd.
• 31.7. Amneal Pharmaceuticals LLC
• 31.8. Lupin Pharmaceuticals Inc.
• 31.9. Glenmark Pharmaceuticals
• 31.10. Mankind Pharma Ltd.
• 31.11. Mayne Pharma
• 31.12. HLL Lifecare Limited
• 31.13. Famy Care Ltd.
• 31.14. Mylan N.V.
• 31.15. Novartis AG

32. Global Oral Contraceptive Pills Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Contraceptive Pills Market

34. Recent Developments In The Oral Contraceptive Pills Market

35. Oral Contraceptive Pills Market High Potential Countries, Segments and Strategies

• 35.1 Oral Contraceptive Pills Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oral Contraceptive Pills Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oral Contraceptive Pills Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer